Pharma Equity Group A/S (CPH: PEG)
Denmark
· Delayed Price · Currency is DKK 0.174
+0.005 (2.65%)
Dec 20, 2024, 3:43 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 213.59 million as of December 20, 2024. Its market cap has decreased by -53.18% in one year.
Market Cap
213.59M
Enterprise Value
256.61M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 213.59M, a decrease of -72.16%. That is a compound annual growth rate of -52.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 213.59M | -51.44% |
| Dec 29, 2023 | 439.87M | -42.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk A/S | 3,413.81B |
| Coloplast A/S | 180.33B |
| Genmab A/S | 94.43B |
| Demant A/S | 57.78B |
| Zealand Pharma A/S | 56.69B |
| H. Lundbeck A/S | 39.25B |
| H. Lundbeck A/S | 39.25B |
| ALK-Abelló A/S | 35.72B |